Advertisement
Screener

JUPITER NEUROSCIENCES, INC. (JUNS) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

JUPITER NEUROSCIENCES, INC. Cash Flow Breakdown

Cash flow breakdown shows where JUPITER NEUROSCIENCES, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $5.41M went out.
  • Fiscal year ended 2025-12-31: from financing, $5.43M came in.
  • Fiscal year ended 2025-12-31: change in cash, $19.83K came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$5.41M$5.43M*$19.83K
2024-12-31-$3.91M$150.00K$7.50M*$3.74M
2023-12-31-$480.95K$55.00K-$35.95K

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$2.29M*$0.00*$1.45M*
2026-03-31-$1.43M$5.51K-$1.43M
2025-12-31-$2.37M*
2025-09-30-$1.15M*
2025-06-30-$828.22K*
2025-03-31-$1.06M-$1.06M
2024-12-31-$3.70M*$100.00K*$7.37M*
2024-09-30-$42.60K*$0.00*
2024-06-30-$107.46K*
2024-03-31-$65.17K-$20.16K
2023-12-31-$161.14K*$0.00*

Similar stocks

Stock NameCountryMarket CapPE Ratio
ORAGENICS INC (OGEN)United States$0.002B
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
Nexentis Technologies Inc. (NXTS)$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Genprex, Inc. (GNPX)United States$0.003B-0.02